OR WAIT 15 SECS
© 2020 MJH Life Sciences and BioPharm International. All rights reserved.
© 2020 MJH Life Sciences™ and BioPharm International. All rights reserved.
Susan Haigney is managing editor of BioPharm International, firstname.lastname@example.org.
The COVID-19 pandemic has created a rise in demand for R&D and a shift in focus for some contract organizations.
Pharmaceutical Technology spoke with Jens Andersson, purchasing director at Cambrex Karlskoga, about the best way to ensure the security of the bio/pharmaceutical materials supply chain.
Risk assessments, audits, and good communication between sponsor and supplier are key elements of supplier oversight.
Contract manufacturers are making strategic partnerships and expanding services in the last quarter of 2019.